Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer.

Awada, A; Ochsenreither, S; Eefsen, RL; Arnold, D; Yachnin, J; Pfeiffer, P; Jungels, C; Greil, R; Poulsen, L; Van Cutsem, E; Thorsson, L; Svedman, C; Garcia-Ribas, I; Collignon, J J CLIN ONCOL. 2021; 39(15):

Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC)

Gadea, OSS; Greil, R; De Jonge, MJA; Tan, D; Jerusalem, G; Damian, S; Grell, P; Wainberg, Z; Wolf, J; Joerger, M; Carlino, MS; Kasper, S; Yap, TA; Otero, J; Yang, X; Nesbitt, V; Kim, J; Lee, LH; Choudhury, S; Leal, TA ANN ONCOL. 2021; 32: S552-S553.

Treatment landscape of HER2-positive metastatic breast cancer (MBC): Results from the Austrian AGMT_MBC-Registry

Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, AL; Balic, M; Heibl, S; Zabernigg, A; Egle, D; Sandholzer, M; Roitner, F; Andel, J; Pichler, P; Hager, C; Hubalek, M; Knauer, M; Singer, CF; Greil, R ANN ONCOL. 2021; 32: S487-S488.

ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor (HER2) positive, early breast cancer (eBC) observing real-life extended adjuvant treatment with neratinib and concurrent use of the eHealth solution CANKADO

Harbeck, N; Luftner, D; Breitenstein, U; Jackisch, C; Muller, V; Schmidt, M; Balic, M; Rinnerthaler, G; Schwitter, M; Zaman, K; Wrobel, D; Guth, D; Terhaag, J; Zaiss, M; Schinkothe, T; Bartsch, R ANN ONCOL. 2021; 32: S444-S444.

Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)

Awada, AH; Zematis, M; Ochsenreither, S; Eefsen, RL; Arnold, D; Cicenas, S; Yachnin, J; Pfeiffer, P; Paz-Ares, L; Jungels, C; Greil, R; Poulsen, LO; Van Cutsem, E; Ribas, IG; Thorsson, L; Collignon, JJ ANN ONCOL. 2021; 32: S602-S603.

Predictive value of gene-expression profiles (GEPs) and their dynamics during therapy in the NeoTRIPaPDL1 trial

Bianchini, G; Dugo, M; Huang, CS; Egle, D; Bermejo, B; Seitz, RS; Nielsen, TJJ; Zamagni, C; Thill, M; Anton, A; Russo, S; Ciruelos, EM; Schweitzer, BL; Greil, R; Semiglazov, V; Gyorffy, B; Valagussa, P; Viale, G; Callari, M; Gianni, L ANN ONCOL. 2021; 32: S1283-S1284.

Radio-Interview anlässlich des Welt-Rheumatages

Oskar Psenak Weltrheumatag; 12.10.2021; Salzburg. 2021.

Radio-Interview anlässlich des Welt-Rheumatages

Oskar Psenak Weltrheumatag; 12.10.2021; Radio Salzburg. 2021.

Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.

Kiem, D; Leisch, M; Neureiter, D; Haslauer, T; Egle, A; Melchardt, T; Topp, MS; Greil, R; Int J Mol Sci. 2021; 22(11):

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Borchmann, P; Plutschow, A; Kobe, C; Greil, R; Meissner, J; Topp, MS; Ostermann, H; Dierlamm, J; Mohm, J; Thiemer, J; Sokler, M; Kerkhoff, A; Ahlborn, M; Halbsguth, TV; Martin, S; Keller, U; Balabanov, S; Pabst, T; Vogelhuber, M; Huttmann, A; Wilhelm, M; Zijlstra, JM; Moccia, A; Kuhnert, G; Brockelmann, PJ; von Tresckow, B; Fuchs, M; Klimm, B; Rosenwald, A; Eich, H; Baues, C; Marnitz, S; Hallek, M; Diehl, V; Dietlein, M; Engert, A LANCET ONCOL. 2021; 22(2): 223-234.